US-Listed Biological Products, (No Diagnostic Substances) — Total Assets Percentiles, FY 2020

Population: 186 US-listed companies (SIC 2836), fiscal year 2020; fiscal year ends 2020-06-30 to 2021-04-30.

Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest

10th percentile	$13.4M
25th percentile	$42.4M
Median	$165.3M
75th percentile	$398.9M
90th percentile	$926.9M
Mean	$1.2B
Minimum	$11.6k
Maximum	$68.4B

Methodology & sources
Total Assets as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2020 = fiscal years ending 2020-06-01 to 2021-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-03.

Evidence samples

Latest Total Assets percentiles (live) · All Biological Products, (No Diagnostic Substances) benchmarks · All industries

Cite as: FACTANKER, https://factanker.com/industries/sic-2836/total-assets/2020